Department of Radiology
Found 6 results
Filters: Author is Fahey, Thomas J  [Clear All Filters]
2023
Limberg J, Egan CE, Gray KD, Singh M, Loewenstein Z, Yang Y, Riascos MCristina, Asadi HAl, Safe P, Eshaky SEl et al..  2023.  Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.. Mol Cancer Res. 21(5):397-410.
2020
Gray KD, McCloskey JE, Vedvyas Y, Kalloo OR, Eshaky SEl, Yang Y, Shevlin E, Zaman M, Ullmann TM, Liang H et al..  2020.  PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.. Clin Cancer Res. 26(22):6003-6016.
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, van Basien K, Gaudet I et al..  2020.  Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 10(1):12733.
2019
Vedvyas Y, McCloskey JE, Yang Y, Min IM, Fahey TJ, Zarnegar R, Hsu Y-MS, Hsu J-M, Van Besien K, Gaudet I et al..  2019.  Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.. Sci Rep. 9(1):10634.
2017
Min IM, Shevlin E, Vedvyas Y, Zaman M, Wyrwas B, Scognamiglio T, Moore MD, Wang W, Park S, Park S et al..  2017.  CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.. Clin Cancer Res. 23(24):7569-7583.
2013
Kleiman DA, Buitrago D, Crowley MJ, Beninato T, Veach AJ, Zanzonico PB, Jin M, Fahey TJ, Zarnegar R.  2013.  Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.. J Surg Res. 182(1):85-93.